| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |